Literature DB >> 18174512

Clinical referral patterns and cognitive profile in mild cognitive impairment.

Jane A Lonie1, Lucie L Herrmann, Claire L Donaghey, Klaus P Ebmeier.   

Abstract

BACKGROUND: There is current interest in exploring the different subtypes of mild cognitive impairment (MCI), in terms of both their epidemiology and their cognitive profile. AIMS: To examine the frequency of MCI subtypes presenting to a memory clinic and to document detailed neuropsychological profiles of patients with the amnestic subtype.
METHOD: Consecutive tertiary referrals (n=187) were psychiatrically evaluated; 45 patients met criteria for amnestic mild cognitive impairment (aMCI). A subgroup of 33 patients with aMCI as well as 21 healthy controls took part in a thorough neuropsychological examination.
RESULTS: Of the patients who were examined in greater neuropsychological detail, ten had pure aMCI (none with visual memory impairment only). Fifteen met criteria for non-amnestic MCI. Fifteen had normal neuropsychological profiles. Using more than one test increased sensitivity to detect episodic memory impairment.
CONCLUSIONS: Amnestic MCI is an important diagnosis in secondary and tertiary memory clinics. There is scope to improve the efficacy and sensitivity of the clinical assessment of this impairment.

Entities:  

Mesh:

Year:  2008        PMID: 18174512     DOI: 10.1192/bjp.bp.107.035642

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  2 in total

Review 1.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

2.  Demographic and clinical characteristics of middle-aged versus younger adults enrolled in a clinical trial of a web-delivered psychosocial treatment for substance use disorders.

Authors:  Raj K Kalapatapu; Aimee Campbell; Efrat Aharonovich; Mei-Chen Hu; Frances R Levin; Edward V Nunes
Journal:  J Addict Med       Date:  2013 Jan-Feb       Impact factor: 3.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.